HIV Infection and Survival Among Women With Cervical Cancer
- 1 November 2016
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (31), 3749-3757
- https://doi.org/10.1200/jco.2016.67.9613
Abstract
Purpose Cervical cancer is the leading cause of cancer death among the 20 million women with HIV worldwide. We sought to determine whether HIV infection affected survival in women with invasive cervical cancer. Patients and Methods We enrolled sequential patients with cervical cancer in Botswana from 2010 to 2015. Standard treatment included external beam radiation and brachytherapy with concurrent cisplatin chemotherapy. The effect of HIV on survival was estimated by using an inverse probability weighted marginal Cox model. Results A total of 348 women with cervical cancer were enrolled, including 231 (66.4%) with HIV and 96 (27.6%) without HIV. The majority (189 [81.8%]) of women with HIV received antiretroviral therapy before cancer diagnosis. The median CD4 cell count for women with HIV was 397 (interquartile range, 264 to 555). After a median follow-up of 19.7 months, 117 (50.7%) women with HIV and 40 (41.7%) without HIV died. One death was attributed to HIV and the remaining to cancer. Three-year survival for the women with HIV was 35% (95% CI, 27% to 44%) and 48% (95% CI, 35% to 60%) for those without HIV. In an adjusted analysis, HIV infection significantly increased the risk for death among all women (hazard ratio, 1.95; 95% CI, 1.20 to 3.17) and in the subset that received guideline-concordant curative treatment (hazard ratio, 2.63; 95% CI, 1.05 to 6.55). The adverse effect of HIV on survival was greater for women with a more-limited stage cancer ( P = .035), those treated with curative intent ( P = .003), and those with a lower CD4 cell count ( P = .036). Advanced stage and poor treatment completion contributed to high mortality overall. Conclusion In the context of good access to and use of antiretroviral treatment in Botswana, HIV infection significantly decreases cervical cancer survival.Keywords
This publication has 47 references indexed in Scilit:
- HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical ChemoradiationInternational Journal of Gynecologic Cancer, 2015
- HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy eraAIDS, 2015
- The Burden of Human Papillomavirus Infections and Related Diseases in Sub-Saharan AfricaVaccine, 2013
- Evaluation of HIV and Highly Active Antiretroviral Therapy on the Natural History of Human Papillomavirus Infection and Cervical Cytopathologic Findings in HIV-Positive and High-Risk HIV-Negative WomenThe Journal of Infectious Diseases, 2013
- Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South AfricaCancer, 2011
- Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected womenGynecologic Oncology, 2010
- Human immunodeficiency virus and human papilloma virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successfulJournal of Translational Medicine, 2009
- Outcomes of Chemoradiotherapy With 5-Fluorouracil and Mitomycin C for Anal Cancer in Immunocompetent Versus Immunodeficient PatientsInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Human Papillomavirus Infection and Cervical Disease in Human Immunodeficiency Virus-1–Infected WomenObstetrics & Gynecology, 2008
- A simple method of obtaining equivalent doses for use in HDR brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000